Safety and Efficacy of Laquinimod Versus Placebo for Relapsing Remitting Multiple Sclerosis

Study Title

Safety and Efficacy of OrFemale, Maley Administered Laquinimod Versus Placebo for Treatment of Relapsing Remitting Multiple Sclerosis (RRMS)

Teva Identifier

MS-LAQ-301 | EUDRACT 2007-003226-19

ClinicalTrials.gov Identifier

NCT00509145

Study Status

Completed

Trial Condition(s)

Multiple Sclerosis

Interventions

Drug: Laquinimod | Other: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Click for participation criteria and map of study locations
neurology icon for clinical trials

Key Participation Requirements

Gender

Female, Male

Age Range

18 Years to 55 Years

Trial Duration

12/01/2007 - 12/01/2010

Phase

Phase 3

Study Type

Interventional